{"title":"'I don't know if there's a happy ending to this story': An analysis of prostate cancer narratives in a follow-up setting.","authors":"Laura Lahti, Piia Jallinoja","doi":"10.1177/13634593251358052","DOIUrl":null,"url":null,"abstract":"<p><p>Prostate cancer, the most common cancer among Finnish men, has a high survival rate. Treatment options vary from active surveillance to radical treatments, with potential long-term or permanent side effects. Traditional cancer narratives frame cancer as a tragedy or a hero story and thus fail to capture the chronic nature of prostate cancer and its impacts on patients' lives. This study analyses the narratives of 22 prostate cancer patients, interviewed twice (1 and 3 years after diagnosis). We found two recurring storylines of prostate cancer narratives, one from radically treated men and the other from men under active surveillance. We analysed how cultural plot types - hero story, tragedy, comedy and irony - appear in the narratives. While tragedy dominated narratives, re-interviews also revealed irony as the tragic elements were caused by the treatment side effects, not the cancer itself. Comedic elements emerged when side effects were reframed as symptoms of ageing. Narratives took on heroic features if the cancer was cured or non-aggressive. The findings underscore the importance of diverse cultural representations to reflect the multifaceted experience of living with prostate cancer and the need for long-term support with the physical and psychological aspects of prostate cancer.</p>","PeriodicalId":12944,"journal":{"name":"Health","volume":" ","pages":"13634593251358052"},"PeriodicalIF":2.3000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13634593251358052","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Prostate cancer, the most common cancer among Finnish men, has a high survival rate. Treatment options vary from active surveillance to radical treatments, with potential long-term or permanent side effects. Traditional cancer narratives frame cancer as a tragedy or a hero story and thus fail to capture the chronic nature of prostate cancer and its impacts on patients' lives. This study analyses the narratives of 22 prostate cancer patients, interviewed twice (1 and 3 years after diagnosis). We found two recurring storylines of prostate cancer narratives, one from radically treated men and the other from men under active surveillance. We analysed how cultural plot types - hero story, tragedy, comedy and irony - appear in the narratives. While tragedy dominated narratives, re-interviews also revealed irony as the tragic elements were caused by the treatment side effects, not the cancer itself. Comedic elements emerged when side effects were reframed as symptoms of ageing. Narratives took on heroic features if the cancer was cured or non-aggressive. The findings underscore the importance of diverse cultural representations to reflect the multifaceted experience of living with prostate cancer and the need for long-term support with the physical and psychological aspects of prostate cancer.
期刊介绍:
Health: is published four times per year and attempts in each number to offer a mix of articles that inform or that provoke debate. The readership of the journal is wide and drawn from different disciplines and from workers both inside and outside the health care professions. Widely abstracted, Health: ensures authors an extensive and informed readership for their work. It also seeks to offer authors as short a delay as possible between submission and publication. Most articles are reviewed within 4-6 weeks of submission and those accepted are published within a year of that decision.